摘要
Abstract
Objective: To analyze brain heart syndrome before and after the treatment of comprehensive application of edaravone, myocardial enzyme levels and significance of BNP.Method: From 2011 May to 2013 October in our hospital for treatment of brain heart syndrome 80 patients were selected as the research object to analyze, who were randomly divided into control group and study group. The two groups were given the same routine treatment, and the study group based on the application of Edaravone injection treatment. The clinical total effective rate, myocardial enzymes (LDH, CK, serum AST, CK-MB and BNP change) between the two groups after two weeks of treatment were compared. Result: The treatment group total effective rate 82.5% was significantly higher than that of the control group 57.5%, with statistically significant differences (P<0.05). Patients with myocardial enzyme indexes (AST, LDH, CK, CK-MB), BNP levels were significantly lower than those of the control group, mean myocardial injury and heart failure were slightly lighter than those of the control group, with statistically significant differences (P<0.05).Conclusion: Application of edaravone in the treatment of cerebral cardiac syndrome in patients with myocardial enzyme and BNP level decreased significantly, can improve symptoms of heart failure, myocardial damage and improve prognosis, has higher application value.关键词
脑心综合征/依达拉奉/心肌酶/BNP/心肌损害Key words
Brain heart syndrome/Edaravone/Myocardial enzymes/BNP/Myocardial damage
